Aptevo Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Aptevo Therapeutics

12/05/2022 22:01

* Aptevo Therapeutics Inc  APVO.OQ  reported a quarterly
adjusted
loss of $1.55​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of $1.15 per share.
    * Revenue rose 28.6% to $3.11 million from a year ago; 
analysts
expected $3.75 million. 
    * Aptevo Therapeutics Inc's reported EPS for the quarter was
a
loss of $1.55​.
    * The mean earnings estimate of analysts had risen by
about 10.2%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Aptevo Therapeutics Inc shares had fallen by 34.9% this
quarter and lost 51.5% so far this year.
    * The company reported a quarterly loss of $7.7 million.
    * Wall Street's median 12-month price target for Aptevo
Therapeutics Inc is $52.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated